Detalles de la búsqueda
1.
DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.
Strahlenther Onkol
; 193(4): 315-323, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28116446
2.
DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer.
Strahlenther Onkol
; 191(3): 256-63, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245469
3.
Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.
Radiat Oncol
; 17(1): 120, 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35799182
4.
Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation.
Strahlenther Onkol
; 186(10): 551-7, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20936459
5.
Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.
Strahlenther Onkol
; 185(8): 512-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19652934
6.
"Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.
Strahlenther Onkol
; 184(2): 93-9, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18259701
7.
A dosimetric comparison of IORT techniques in limited-stage breast cancer.
Strahlenther Onkol
; 182(6): 342-8, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16703290
8.
Radiotherapy planning for lung cancer: slow CTs allow the drawing of tighter margins.
Radiother Oncol
; 75(2): 165-70, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16086907
9.
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Radiat Oncol
; 10: 121, 2015 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018527
10.
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.
Radiat Oncol
; 8: 49, 2013 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497555
11.
First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Int J Radiat Oncol Biol Phys
; 83(5): 1624-32, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22209149
12.
Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Int J Radiat Oncol Biol Phys
; 77(5): 1345-51, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19910140
13.
Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans.
Radiat Oncol
; 4: 30, 2009 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19678961
14.
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.
Strahlenther Onkol
; 184(12): 663-7, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19107347
15.
NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Strahlenther Onkol
; 183 Spec No 2: 38-40, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18167008
Resultados
1 -
15
de 15
1
Próxima >
>>